320 related articles for article (PubMed ID: 34502166)
1. Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy.
Tsai CH; Lin YH; Li YS; Ho TL; Hoai Thuong LH; Liu YH
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502166
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice.
Beijers AJ; Vreugdenhil G; Oerlemans S; Eurelings M; Minnema MC; Eeltink CM; van de Poll-Franse LV; Mols F
Support Care Cancer; 2016 Jun; 24(6):2411-20. PubMed ID: 26634561
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy-induced peripheral neuropathy; impact on quality of life].
Scheel A; Beijers AJ; Mols F; Faber CG; Vreugdenhil G
Ned Tijdschr Geneeskd; 2014; 158():A7455. PubMed ID: 25315326
[TBL] [Abstract][Full Text] [Related]
4. Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Liu Y; May BH; Zhang AL; Guo X; Lu C; Xue CC; Zhang H
Integr Cancer Ther; 2019; 18():1534735418817833. PubMed ID: 30526124
[TBL] [Abstract][Full Text] [Related]
5. Short-term recovery of chemotherapy-induced peripheral neuropathy after treatment for pediatric non-CNS cancer.
Gilchrist LS; Tanner LR; Ness KK
Pediatr Blood Cancer; 2017 Jan; 64(1):180-187. PubMed ID: 27567009
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
Kachrani R; Santana A; Rogala B; Pawasauskas J
J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):141-152. PubMed ID: 32118502
[TBL] [Abstract][Full Text] [Related]
7. Recent Developments of Novel Pharmacologic Therapeutics for Prevention of Chemotherapy-Induced Peripheral Neuropathy.
Hu S; Huang KM; Adams EJ; Loprinzi CL; Lustberg MB
Clin Cancer Res; 2019 Nov; 25(21):6295-6301. PubMed ID: 31123053
[TBL] [Abstract][Full Text] [Related]
8. Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.
Schloss J; Colosimo M; Vitetta L
Crit Rev Food Sci Nutr; 2017 Apr; 57(6):1107-1118. PubMed ID: 25849070
[TBL] [Abstract][Full Text] [Related]
9. Integrative Approaches to Chemotherapy-Induced Peripheral Neuropathy.
Samuels N; Ben-Arye E
Curr Oncol Rep; 2020 Feb; 22(3):23. PubMed ID: 32048067
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Chemotherapy-Induced Peripheral Neuropathy.
Zajączkowska R; Kocot-Kępska M; Leppert W; Wrzosek A; Mika J; Wordliczek J
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909387
[TBL] [Abstract][Full Text] [Related]
11. Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time.
Wang M; Cheng HL; Lopez V; Sundar R; Yorke J; Molassiotis A
BMC Cancer; 2019 Nov; 19(1):1151. PubMed ID: 31775665
[TBL] [Abstract][Full Text] [Related]
12. Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN).
Hertz DL; Childs DS; Park SB; Faithfull S; Ke Y; Ali NT; McGlown SM; Chan A; Grech LB; Loprinzi CL; Ruddy KJ; Lustberg M
Cancer Treat Rev; 2021 Sep; 99():102241. PubMed ID: 34174668
[TBL] [Abstract][Full Text] [Related]
13. Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review.
Schloss JM; Colosimo M; Airey C; Masci PP; Linnane AW; Vitetta L
Clin Nutr; 2013 Dec; 32(6):888-93. PubMed ID: 23647723
[TBL] [Abstract][Full Text] [Related]
14. Exploring the impact of a decision support algorithm to improve clinicians' chemotherapy-induced peripheral neuropathy assessment and management practices: a two-phase, longitudinal study.
Knoerl R; Mazzola E; Hong F; Salehi E; McCleary N; Ligibel J; Reyes K; Berry DL
BMC Cancer; 2021 Mar; 21(1):236. PubMed ID: 33676431
[TBL] [Abstract][Full Text] [Related]
15. Lived experiences and support needs of women who developed chemotherapy-induced peripheral neuropathy following treatment for breast and ovarian cancer.
Tanay MA; Armes J
Eur J Cancer Care (Engl); 2019 May; 28(3):e13011. PubMed ID: 30790382
[TBL] [Abstract][Full Text] [Related]
16. Management of side effects in the personalized medicine era: chemotherapy-induced peripheral neuropathy.
Alberti P; Cavaletti G
Methods Mol Biol; 2014; 1175():301-22. PubMed ID: 25150874
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.
Hausheer FH; Schilsky RL; Bain S; Berghorn EJ; Lieberman F
Semin Oncol; 2006 Feb; 33(1):15-49. PubMed ID: 16473643
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic strategies for cancer treatment related peripheral neuropathies.
Pachman DR; Watson JC; Loprinzi CL
Curr Treat Options Oncol; 2014 Dec; 15(4):567-80. PubMed ID: 25119581
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-Induced Peripheral Neuropathy: Diagnosis, Agents, General Clinical Presentation, and Treatments.
Molinares D; Kurtevski S; Zhu Y
Curr Oncol Rep; 2023 Nov; 25(11):1227-1235. PubMed ID: 37702983
[TBL] [Abstract][Full Text] [Related]
20. Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling.
Michel A; Lee RT; Salehi E; Accordino MK
Am Soc Clin Oncol Educ Book; 2023 Jun; 43():e390428. PubMed ID: 37267515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
